SCHEMBL8227247

SCHEMBL8227247

C=C(C)NCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12091637 0.82
SCHEMBL2640818 0.80
SCHEMBL15721587 0.78 EPHX1 (0.56)
SCHEMBL21078022 0.78 EPHX1 (0.56)
SCHEMBL20049728 0.78 EPHX1 (0.56)
SCHEMBL18602569 0.78 EPHX1 (0.56)
SCHEMBL21086937 0.78 EPHX1 (0.56)
SCHEMBL20648013 0.78 EPHX1 (0.56)
SCHEMBL25951118 0.78 EPHX1 (0.56)
SCHEMBL15429197 0.78 MCL1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114229871-B Method for improving stability of evaporation system of byproduct brine of ketone hydrazine hydrate 宜宾海丰和锐有限公司 2024-02-13 CN disclosed
US-11672787-B2 Compounds as mPGES-1 inhibitors KHONDRION IP B.V. (NL) 2023-06-13 US disclosed
CN-114574090-B Anti-dazzle and anti-scratch functional film for display and preparation method and application thereof 宁波集科威视讯有限公司 2022-11-04 CN disclosed
CN-216687790-U Ketone method hydrazine hydrate byproduct salt water evaporation mother liquor processing system 宜宾海丰和锐有限公司 2022-06-07 CN disclosed
CN-114574090-A Anti-dazzle and anti-scratch functional film for display and preparation method and application thereof 宁波集科威视讯有限公司 2022-06-03 CN disclosed
CN-114229871-A Method for improving stability of ketone method hydrazine hydrate byproduct salt water evaporation system 宜宾海丰和锐有限公司 2022-03-25 CN disclosed
WO-2021124222-A1 PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-06-24 WO disclosed
WO-2021104710-A1 METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS BEEN DYED USING AN AMINO SILICONE AND A PIGMENT HENKEL AG & CO. KGAA (DE) 2021-06-03 WO disclosed
WO-2019042267-A1 PYRROLE-2-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF 中国医学科学院药物研究所 2019-03-07 WO disclosed
US-9923154-B2 Organic electroluminescent element, lighting device, and display device Konica Minolta, Inc. (JP) 2018-03-20 US disclosed
WO-2017124087-A1 ANTI-PARASITIC COMPOUNDS AND USES THEREOF MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2017-07-20 WO disclosed
WO-2017060432-A1 NOVEL COMPOUNDS FOR TREATING MITOCHONDRIAL DISEASE KHONDRION IP B.V. (NL) 2017-04-13 WO disclosed
US-9388156-B2 Chromanyl derivatives for treating mitochondrial disease Khondiron IP B.V. (NL) 2016-07-12 US disclosed
US-9388156-B2 Chromanyl derivatives for treating mitochondrial disease Khondiron IP B.V. (NL) 2016-07-12 US disclosed
US-20150166501-A1 CHROMANYL DERIVATIVES FOR TREATING MITOCHONDRIAL DISEASE KHONDRION IP B.V. (NL) 2015-06-18 US disclosed
US-20150166501-A1 CHROMANYL DERIVATIVES FOR TREATING MITOCHONDRIAL DISEASE KHONDRION IP B.V. (NL) 2015-06-18 US disclosed
CN-104529049-A Treatment method for using ketazine process hydrazine hydrate brine waste in ion exchange membrane electrolysis YIBIN TIANYUAN GROUP CO LTD 2015-04-22 CN disclosed
WO-2014100719-A2 PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-06-26 WO disclosed
WO-2007100374-A9 SOFT PROTEASE INHIBITORS AND PRO-SOFT FORMS THEREOF TUFTS COLLEGE (US) 2007-12-06 WO disclosed
WO-2007100374-A2 SOFT PROTEASE INHIBITORS AND PRO-SOFT FORMS THEREOF TRUSTEES OF TUFTS COLLEGE (US) 2007-09-07 WO disclosed